[1]
“ Dilution of botulinum toxin type A in local anesthetics: a therapeutic opportunity in migraine treatment”, Headache Med, vol. 15, no. 2, pp. 43–46, Jun. 2024, doi: 10.48208/HeadacheMed.2024.12.